Journal Mobile Options
Table of Contents
Vol. 22, No. 2, 2004
Issue release date: 2004
Dig Dis 2004;22:196–201

What Parameters Are Relevant for the Histological Diagnosis of Gastroesophageal Reflux Disease without Barrett’s Mucosa?

Vieth M. · Peitz U. · Labenz J. · Kulig M. · Nauclér E. · Jaspersen D. · Meyer-Sabellek W. · Willich S. · Lind T. · Malfertheiner P. · Stolte M.
aInstitute of Pathology and bDepartment of Gastroenterology and Hepatology, Otto-Von-Guericke University, Magdeburg; cDepartment of Medicine II, Klinikum Fulda; dEv.-Jung-Stilling Krankenhaus, Siegen, Germany; eAstraZeneca GmbH, Wedel; fUniversity Hospital, Charité, Berlin, Germany; gAstraZeneca R&D Mölndal, Sweden; hInstitute of Pathology, Klinikum Bayreuth, Bayreuth, Germany

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Background/Aims: There are still ongoing controversies as to which histological parameters allow the diagnosis of gastroesophageal reflux disease (GERD). The aim of the present analysis was to relate histological changes of the esophageal squamous epithelium to different severities of GERD. Methods: Data were obtained from patients participating in the ProGERD study, who had either erosive reflux disease (ERD, n = 3,245) or non-erosive reflux disease (NERD, n = 2,970). 1,475 patients fulfilled our requirement of having complete biopsy data from two sites (2 cm above the z-line and at the z-line). Changes in the squamous epithelium were assessed by measuring the thickness of the basal cell layer and elongation of the papillae as a percentage of the whole epithelial thickness and counting interepithelial inflammatory cells. Results: The most useful parameters for histological assessment of GERD (given as means, 2 cm above the z-line and at the z-line, respectively) were elongation of the papillae: NERD 40.7 and 48.9%; ERD 46.1 and 54.9% and basal cell hyperplasia: NERD 12.7 and 17.9%; ERD 15.7 and 23.0%. The occurrence of intraepithelial lymphocytic infiltrates, however, is dependent on the severity of GERD, and they are more common than neutrophilic and eosinophilic granulocytes. Conclusion: This study shows that both NERD and ERD can be diagnosed histologically if biopsies are obtained from the distal esophagus or from the z-line. Intraepithelial inflammatory cells are rare and show a high specificity, but very low sensitivity.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Ismail-Beigi F, Horton PF, Pope CE 2nd: Histological consequences of gastroesophageal reflux in man. Gastroenterology 1970;58:163–174.
  2. Ismail-Beigi F, Pope CE 2nd: Distribution of the histological changes of gastroesophageal reflux in the distal esophagus of man. Gastroenterology 1974;66:1109–1113.
  3. Zeitoun P, Pluot M, Vandromme L, Casola M: Evaluation by endoscopic biopsies, of the histological criteria of reflux esophagitis. Gastroenterol Clin Biol 1987;11:6–11.
  4. Yamada T, Takizawa T: Diagnosis of gastroesophageal reflux disease: Pathology of gastroesophageal reflux: a morphological viewpoint. Nippon Naika Gakkai Zasshi 2000;89:53–61.
  5. Leape LL, Bhan I, Ramenofsky ML: Esophageal biopsy in the diagnosis of reflux esophagitis. J Pediatr Surg 1981;16:379–384.
  6. Sbarbati A, Ricci F, Inaspettato G, Lazzara G, Cordiano C, Osculati F: Microvascular lesions in reflux oesophagitis and Barrett’s oesophagus. J Pathol 1994;173:61–64.
  7. Vadva MD, Triadafilopoulos G: Glycogenic acanthosis of the esophagus and gastroesophageal reflux. J Clin Gastroenterol 1993;17:79–83.
  8. Jessurun J, Yardley JH, Giardiello FM, Hamilton SR: Intracytoplasmic plasma proteins in distended esophageal squamous cells (balloon cells). Mod Pathol 1988;1:175–181.
  9. Solcia E, Villani L, Luinetti O, Trespi E, Strada E, Tinelli C, Fiocca R: Altered intercellular glycoconjugates and dilated intercellular spaces of esophageal epithelium in reflux disease. Virchows Arch 2000;436:207–216.
  10. Calabrese C, Fabbri A, Bortolotti M, Cenacchi G, Areni A, Scialpi C, Miglioli M, Di Febo G: Dilated intercellular spaces as a marker of oesophageal damage: comparative results in gastro-oesophageal reflux disease with or without bile reflux. Aliment Pharmacol Ther 2003;18:525–532.
  11. Ferey L, Herlin P, Marnay J, Jacob JH, De Raucourt D, Gignoux M, Segol P, Ollivier JM, Mandard AM: Histology and ultrastructure of the human esophageal epithelium. I. Normal and parakeratotic epithelium. J Submicrosc Cytol 1985;17:651–665.
  12. Ottenjann R, Seib HJ: Endoscopic biopsy study for staging of reflux esophagitis. Z Gastroenterol 1991;29:360–362.
  13. Vieth M, Haringsma J, Delarive J, Wiesel PH, Tam W, Dent J, Tytgat GN, Stolte M, Lundell L: Red streaks in the oesophagus in patients with reflux disease: Is there a histomorphological correlate? Scand J Gastroenterol 2001;36:1123–1127.

    External Resources

  14. Sladen GE, Riddell RH, Willoughby JM: Oesophagoscopy, biopsy, and acid perfusion test in diagnosis of ‘reflux oesophagitis’. Br Med J 1975;i:71–76.
  15. Weinstein WM, Bogoch ER, Bowes KL: The normal human esophageal mucosa: A histological reappraisal. Gastroenterology 1975;68:40–44.
  16. Seefeld U, Krejs GJ, Siebenmann RE, Blum AL: Esophageal histology in gastroesophageal reflux: Morphometric findings in suction biopsies. Am J Dig Dis 1977;22:956–964.
  17. Collins JS, Watt PC, Hamilton PW, Collins BJ, Sloan JM, Elliott H, Love AH: Assessment of oesophagitis by histology and morphometry. Histopathology 1989;14:381–389.
  18. Sonnenberg A, Lepsien G, Müller-Lissner SA, Koelz HR, Siwert JR, Blum AL: When is esophagitis healed? Esophageal endoscopy, histology and function before and after cimitidine treatment. Dig Dis 1982;27:297–302.
  19. Stolte M, Vieth M; Schmitz JM, Funken C, Fuchs W, Hotz J: Comparative investigation of the effects of lansoprazole and ranitidine on the histological findings of gastro-oesophageal reflux disease. Leber Magen Darm 1998;28:24–32.
  20. Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, Johnson F, Hongo M, Richter JE, Spechler SJ, Tytgat GN, Wallin L: Endoscopic assessment of oesophagitis: Clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45:172–180.
  21. Winter HS, Madara JL, Stafford RJ, Grand RJ, Quinlan JE, Goldman H: Intraepithelial eosinophils: A new diagnostic criterion for reflux esophagitis. Gastroenterology 1982;83:818–823.
  22. Attwood SE, Smyrk TC, Demeester TR, Jones JB: Esophageal eosinophilia with dysphagia: A distinct clinicopathologic syndrome. Dig Dis Sci 1993;38:109–116.
  23. Fox VL, Nurko S, Furuta GT: Eosinophilic esophagitis: It’s not just kid’s stuff. Gastrointest Endosc 2002;56:260–270.
  24. Khan S, Orenstein SR, Di Lorenzo C, Kocoshis SA, Putnam PE, Sigurdsson L, Shalaby TM: Eosinophilic esophagitis: Strictures, impactions, dysphagia. Dig Dis Sci 2003;48:22–29.
  25. Straumann A, Rossi L, Simon HU, Heer P, Spichtin HP, Beglinger C: Fragility of the esophageal mucosa: A pathognomonic endoscopic sign of primary eosinophilic esophagitis? Gastrointest Endosc 2003;57:407–412.
  26. Ahmad M, Soetikno RM, Ahmed A: The differential diagnosis of eosinophilic esophagitis. J Clin Gastroenterol 2000;30:242–244.
  27. Levine MS, Saul SH: Idiopathic eosinophilic esophagitis: How common is it? Radiology 1993;186:631–632.
  28. Attwood SE, Lewis CJ, Bronder CS, Morris CD, Armstrong GR, Whittam J: Eosinophilic oesophagitis: A novel treatment using Montelukast. Gut 2003;52:181–185.
  29. Grove O, Bekker C, Jeppe-Hansen MG, Karstoft E, Sanchez G, Axelsson CK, Nielsen HO, Andersen B, Rask-Madsen J: Ranitidine and high-dose antacid in reflux oesophagitis: A randomized, placebo-controlled trial. Scand J Gastroenterol 1985;20:457–461.
  30. Heilmann KL, Siewert JR, Ottenjann R, Neiss A, Döpfer H: Histomorphology of esophageal reflux disease: results of biopsy histology in a multicentre trial with cimitidine; in Siewert JR, Hölscher AH (eds): Diseases of the Esophagus. Berlin, Springer, 1987.
  31. Stolte M, Vieth M, Schmitz JM, Alexandridis T, Seifert E: Effects of long-term treatment with proton pump inhibitors in gastro-oesophageal reflux disease on the histological findings in the lower oesophagus. Scand J Gastroenterol 2000;35:1125–1130.
  32. Fletscher J, Wirz A, Henry E, McColl KEL: Studies of acid exposure immediately above the gastro-oesophageal squamocolumnar junction: Evidence of short segment reflux. Gut 2004;53:168–173.
  33. Hirschowitz BI: Nonsteroidal anti-inflammatory drugs and the gut. South Med J 1996;89:259–263.
  34. Soll AH, McCarthy D: NSAID-related gastrointestinal complications. Clin Cornerstone 1999;1:42–56.
  35. Bennett J: ABC of the upper gastrointestinal tract. Oesophagus: Atypical chest pain and motility disorders. BMJ 2001;323:791–794.
  36. Stermer E: Alcohol consumption and the gastrointestinal tract. Isr Med Assoc J 2002;4:200–202.
  37. Vieth M, Gossner L, Stolte M: Volkskrankheit Reflux. Bestandsaufnahme, Konsequenzen für die Praxis, Blick in die Zukunft. Leber Magen Darm 2000;(suppl II):1–30.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50